crc-23-0185-s10.pdf (123.43 kB)
Table S5 from Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment
journal contribution
posted on 2023-09-06, 17:38 authored by Jiahui Liu, Wenqiang Yan, Huishou Fan, Jingyu Xu, Lingna Li, Chenxing Du, Xuehan Mao, Yuting Yan, Yan Xu, Weiwei Sui, Shuhui Deng, Shuhua Yi, Kenneth C. Anderson, Lugui Qiu, Dehui Zou, Gang AnPatient and Treatment Characteristics in ASCT cohort: Sustained MRD-negative vs. Sustained MRD-positive